Company Meetings - Sun Pharmaceutical Industries Ltd.
Search Company
Registered Address
Registered Office : Sun Pharma Advanced Research Centre (SPARC), Tandalja,
Vadodra, Gujarat - 390012
Tel: 0265-6615500, 6615600, 6615700
Fax: 0265-2354897
Email : secretarial@sunpharma.com
Website : http://www.sunpharma.com
Key Officials
Name Designation
Mr. Anoop Deshpande Co. Secretary & Compl. Officer
Mr. C S Muralidharan Chief Financial Officer
Mr. Abhay Gandhi CEO - North America
Listings
BSE , BSE , MCXSX , NSE , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Dec 24 Sep 24 Jun 24
Sales 6,191.81 5,127.71 4,498.07
Other Income 68.39 86.30 82.74
Total Expenses 4,120.86 3,429.00 3,430.74
Operating Profit 2,070.95 1,698.71 1,067.33
Interest 215.96 243.75 216.08
Gross Profit 1,555.90 1,181.17 627.73
Provisions Made 0.00 0.00 0.00
Depreciation 290.97 285.53 369.81
Taxation 83.88 32.35 20.10
Net Profit / Loss 1,181.05 863.29 237.82
Equity Capital 239.93 239.93 239.93
Balance Sheet
Mar 24 Mar 23 Mar 22
Share Capital 239.93 239.93 239.93
Reserve & Surplus 23,454.47 23,508.43 24,348.02
Revaluation Reserve 0.00 0.00 0.00
Networth 23,694.40 23,748.36 24,587.95
Total debt 11,046.61 7,592.67 4,868.71
Total Liability 34,741.01 31,341.03 29,456.66
Net Block 7,736.74 8,711.67 9,712.78
Capital work in progress 766.11 852.91 828.64
Investment 12,429.97 12,616.40 15,548.87
Net current asset 13,808.19 9,160.05 3,366.37
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 34,741.01 31,341.03 29,456.66
Income Statement
  Mar24 Mar23 Mar22
Sales 20,275.17 20,812.14 15,585.98
Other Income 465.76 279.03 957.92
Total Expenses 14,687.56 14,339.28 12,678.46
Operating Profit 5,587.61 6,472.86 2,907.52
Interest 784.08 472.18 388.10
Adjusted PBDIT 6,053.37 6,751.89 3,865.44
Depreciation 1,600.62 1,600.87 1,349.95
Adjusted PBT 3,668.67 4,678.84 2,127.39
Taxation 591.47 50.33 406.85
Net Profit / Loss 2,858.18 1,690.72 -99.99
Key Ratios
  Mar24 Mar23 Mar22
OPM (%) 27.55 31.10 18.65
GPM (%) 19.66 23.40 9.99
NPM (%) 14.09 8.12 -0.64
Earning Retention Ratio 5.82 45.57 -25.47
Return on networth (%) 12.06 7.11 -0.40
EPS (Rs.) 11.91 7.05 -0.41
Dividend payout Ratio 101.39 149.00 0.00
Longterm Debt-Equity Ratio 0.46 0.31 0.19
Current Ratio 3.18 1.95 1.30
Fixed Asset Turnover Ratio 0.61 0.68 0.51
Inventory 0.58 0.66 0.52
Interest coverage Ratio 7.72 14.30 9.96
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel : 022-49186270
Fax : 49186060
Market Performance
Exchange BSE NSE
Last Traded Price (Rs.) 1,828.75 1,829.40
Last Traded Date 02/05/2025 02/05/2025
Last Traded Time - -
Change (%) -0.08% -0.16%
Day's Open (Rs.) 1,832.05 1,832.30
Previous Close (Rs.) 1,830.20 1,832.30
Day's High (Rs.) 1,850.95 1,851.20
Day's Low (Rs.) 1,814.05 1,813.80
Volume (Rs. In Lacs) 1971.47 42299.82
Bid Price (Rs.) 0.00 0.00
Bid Quantity
Offer Price (Rs.) 0.00 0.00
Offer Quantity
Exchange Code 524715 SUNPHARMAEQ
Exchange Group A Nifty
Board Meetings
Date Purpose
31/01/2025 Quarterly Results & Interim Dividend
28/10/2024 Quarterly Results
01/08/2024 Quarterly Results
Corporate News
Sun Pharma. - Press Release
Sun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
Sun Pharma. - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sun Pharma. - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Or
Share Holding Pattern as on 31/12/2024
Major Holder No. of Shares Percentage (%)
Promoters 1,307,134,535 54.48
Institutional Investors 878,065,610 36.60
Other Investors 82,989,049 3.46
General Public 131,145,776 5.47